Navigation Links
Global Pharm Holdings Group Announces Fiscal Year 2010 Financial Results
Date:4/14/2011

nd 2009:For the Years Ended December 31 – Revenuein USD except percentage

2010

2009

Change% of revenue% of revenue%Pharmaceutical products distribution

$97,632,578

69.6

$59,179,450

68.2

$38,453,128

65.0TCM processing and distribution

22,463,998

16.0

14,844,372

17.1

7,619,626

51.3Herbal cultivation and sales

15,390,594

11.0

7,500,814

8.6

7,889,780

105.2Flower tea bags

4,855,608

3.4

5,259,366

6.1

(403,758)

(7.7)Total

$140,342,778

100

$86,784,002

100

$53,558,776

61.7The sales growth of pharmaceutical products distribution, generated by the Company's subsidiaries Yaoyuan, was mainly due to the Company securing exclusive distribution rights from two pharmaceutical manufactures in Shandong province in early 2010, which granted Global Pharm the rights to sell a total of over 680 kinds of products exclusively in Shandong province.

The growth of the Company's TCM processing and distribution business, generated by its subsidiary Xuelingxian, was primarily due to the expansion of the product portfolio and the price volatility of TCM products, as well as the increased demand from hospitals, pharmacy shops and neighborhood clinics.

The growth in the herbal cultivation and sales segment, generated by the Company's subsidiaries Xuelingxian, was primarily due to the additional land leased for plantation, the growth in sales of herbs harvested in 2010, as well as the increase in prices of certain herbs in 2010.

The year-over-year decrease in sales of flower tea bags for 2010 was mainly due to increased competition in the market.  

Gross Profit for the twelve months ended December 31, 2010 was $26.4 million, an increase of 64.5% from $16.1 million in the same period a year ago. Gross margin was 18.8% com
'/>"/>

SOURCE Global Pharm Holdings Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. The American Chamber of Commerce in Spain Awards the Global Business Leader Award 2011 to Victor Grifols Roura, President and CEO of Grifols
2. Tibotec Advances Global Clinical Research Program for TMC435 in HCV; Will Present Four Abstracts Evaluating Safety and Efficacy at EASL
3. Reportlinker Adds Quantum Dots: Technologies and Global Markets
4. Reportlinker Adds Global Angiongenesis Inhibitors and Stimulators Industry
5. Reportlinker Adds Global Nanobiotechnology Industry
6. Reportlinker Adds Global Biochips Industry
7. Top 5 Global Pharmaceutical Company Selects NewCardios QTinno for 2 Upcoming Phase I Drug Safety Trials
8. Global Growth Factors ( Blood And Tissue ) Industry
9. Global HPLC Systems & Accessories Industry
10. Global Specialty Enzymes Industry
11. BioNeutral Enters into Global Sales and Distribution Agreement with Raymond Associates to Expand Market for Military-Grade Ygiene(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2015)... Calif. , May 20, 2015 ... today presented preliminary data demonstrating the ability of ... pulmonary fibrosis (IPF) from other interstitial lung diseases ... suggest the classifier,s potential to help thousands of ... resolve ambiguity in IPF diagnosis – a frequent ...
(Date:5/20/2015)... 2015 The global genotyping market is ... the forecast period of 2015 to 2020 to reach ... in drug discovery and development process and to provide ... addition to this,heavy investments by key manufacturers to offer ... propelling market growth. Browse 113 market data tables & ...
(Date:5/20/2015)... , May 20, 2015  Cypher Genomics, ... a collaboration with Celgene Corporation to apply Cypher,s ... biomarkers that associate with patient response to innovative ... intended to help accelerate patient access to the ... in clinical research and development and potentially inform ...
(Date:5/20/2015)... 20, 2015 The Greater Gift ... organization, is pleased to announce they are donating 10,010 ... These donations represent the effort and commitment of clinical ... GGI partner sites in 2014. , With a ... good of clinical trial participation, GGI supports International Clinical ...
Breaking Biology Technology:Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 2Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 3Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 4Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 5Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 2Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 3Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 4Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 5Cypher Genomics Collaborates with Celgene Corporation to Identify Novel Genomic Biomarkers 2The Greater Gift Initiative Donates over 10,000 Vaccines in Honor of International Clinical Trials Day 2
... Professor of Physics Dr. Satyendra Kumar recently was ... its Directors Award for Excellence for recognition of ... condensed matter physics proposals. In all, seven program ... in Arlington, Va. , The NSF Directors ...
... Data Demonstrated Improved Progression-free Survival with Campath, ... Corp. (Nasdaq: GENZ ) and Bayer HealthCare ... the U.S. Food and Drug Administration,(FDA) has approved ... and granted regular approval for single-agent,Campath for the ...
... (Nasdaq: CADX ), a biopharmaceutical company focused ... use in the hospital setting, announced today that ... the corporate overview on,Thursday, September 27, 2007 at ... the UBS 2007 Global Life Sciences Conference in ...
Cached Biology Technology:FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia 2FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia 3FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia 4FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia 5FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia 6Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at UBS 2007 Global Life Sciences Conference 2
(Date:5/19/2015)... NEW YORK , May 19, 2015  Technology ... resources both internally and in the cloud. Passwords and ... the use of OTP and standards-based specifications such as ... that the outmoded use of passwords presents for BYOD, ... needs a unified biometric identity protocol. ...
(Date:5/11/2015)... SAN JOSE, Calif. , May 11, 2015 ... leading developer of human interface solutions, today announced ... Senior Vice President and Chief Financial Officer, reporting ... Mr. Ali replaces Synaptics, current Chief Financial Officer, ... in December 2014. Mr. Ali ...
(Date:5/7/2015)... , May 7, 2015 ... sensors, FPC1022 and FPC1035, FPC,s smallest touch fingerprint ... are mainly considered for integration on the backside ... smartphone OEMs increased possibilities to integrate touch fingerprint ... size also improves possibilities for module manufacturers to ...
Breaking Biology News(10 mins):HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 2HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 3Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2FPC Introduces its Smallest Touch Fingerprint Sensors to Date 2
... 22, 2013 More accurate and precise assessment of ... a particular gene that are present in a genome, ... cancer and other diseases including autoimmune disorders. However, ... labor intensive, or prohibitively costly, diminishing their effectiveness in ...
... soil and leaks out as nitrate for decades towards groundwater ... at the University of Calgary say in a new study. ... applied to crops in 1982, about 15 per cent of ... scientists found. After three decades, approximately 10 per cent ...
... It has long been known that the characteristics of many ... in climate. But changes in grazing pressure and pollination can ... to a new study. Researchers at Uppsala University and ... the journal Proceedings of the National Academy of Sciences ...
Cached Biology News:Bio-Rad's Droplet Digital PCR technology highlighted at ASHG Annual Meeting 2Nitrogen fertilizer remains in soils and leaks towards groundwater for decades, researchers find 2Nitrogen fertilizer remains in soils and leaks towards groundwater for decades, researchers find 3Grazers and pollinators shape plant evolution 2
...
Recombinant Rat Leptin, CF...
Adhesive seal-tab, for HybriWell™ hybridization sealing system *set of 400*...
... The CultureWell cell culture systems provide ... cells for staining and imaging. Each ... with standard optical-quality coverslips in cell ... provided sterile and ready to use. ...
Biology Products: